Skip to main content
An official website of the United States government

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Evans Williams, Felicia, M.B.A.
felicia.evanslong@nih.gov
240-276-5076
5E636 Program Analyst | Cancer Biomarkers
Fu, Sidney, M.D.
sidney.fu@nih.gov
240-276-6669
5E134 Program Officer | Cancer Biomarkers
Hodges, Nicholas, Ph.D.
nick.hodges@nih.gov
240-276-7844
5E616 Program Officer | Cancer Biomarkers
Kohaar, Indu, Ph.D., M.Phil., M.Sc.
indu.kohaar@nih.gov
240-620-0875
5E612 Program Officer | Cancer Biomarkers
Krueger, Karl, Ph.D. [V]
karl.krueger@nih.gov
Volunteer | Cancer Biomarkers
Marquez, Guillermo, Ph.D.
guillermo.marquez@nih.gov
240-276-7035
5E132 Program Officer | Cancer Biomarkers
Orr, Susan
susan.orr@nih.gov
240-276-5001
5E626 Program Support Assistant | Cancer Biomarkers
Patriotis, Christos, Ph.D., M.Sc.
christos.patriotis@nih.gov
240-276-7134
5E614 Deputy Chief | Cancer Biomarkers
Petruzzelli, Angie
angie.petruzzelli@nih.gov
240-276-5076
5E624 Program Support Assistant | Cancer Biomarkers
Srivastava, Sudhir, Ph.D., M.P.H.
sudhir.srivastava@nih.gov
240-276-7028
5E136 Chief | Cancer Biomarkers
Villanueva, Juan Miguel
juan.villanueva@nih.gov
5E630 Program Analyst | Cancer Biomarkers
Wang, Wendy, Ph.D., M.Sc.
wendy.wang@nih.gov
240-276-7117
5E566 Program Officer | Cancer Biomarkers
Young, Matthew, Ph.D.
matthew.young@nih.gov
240-276-5846
5E610 Program Officer | Cancer Biomarkers

Grants

PI Name PI Organization Title Grant Number Program Official Sort descending
Shah, Sohrab P

Sloan-Kettering Inst Can Research
United States

Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer 5R01CA281928-03 Christos Patriotis, Ph.D., M.Sc.
Linnes, Jacqueline

Purdue University
United States

Point-of-care screening test for early cervical cancer detection 5R01CA246315-05 Christos Patriotis, Ph.D., M.Sc.
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies 5R33CA272321-03 Christos Patriotis, Ph.D., M.Sc.
Figueiredo, Jane C.

Cedars-Sinai Medical Center
United States

Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2 3U54CA260591-02S4 Christos Patriotis, Ph.D., M.Sc.
Labaer, Joshua

Arizona State University-Tempe Campus
United States

High-throughput immunoproteomics for cancer biomarker discovery 5U2CCA271903-04 Christos Patriotis, Ph.D., M.Sc.
Yaghjyan, Lusine

University Of Florida
United States

Stromal contributions to breast carcinogenesis 5R01CA277817-03 Christos Patriotis, Ph.D., M.Sc.
Yuan, Ying

University Of Tx Md Anderson Can Ctr
United States

Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions 5U24CA274212-04 Christos Patriotis, Ph.D., M.Sc.
Wu, Yun

State University Of New York At Buffalo
United States

Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay 4R01CA272827-04 Christos Patriotis, Ph.D., M.Sc.
Pozdeyev, Nikita

University Of Colorado Denver
United States

Genetic architecture of thyroid cancer and its clinical utility 5R21CA282380-02 Wendy Wang, Ph.D., M.Sc.
Wei, Lei

Roswell Park Cancer Institute Corp
United States

Advancing skin cancer prevention by tackling UV-induced clonogenic mutations 5R01CA255242-05 Wendy Wang, Ph.D., M.Sc.
Anderson, Karen Sue

Arizona State University-Tempe Campus
United States

Southwest EDRN Clinical Validation Center for Head and Neck Cancer 5U01CA281660-03 Wendy Wang, Ph.D., M.Sc.
Badve, Sunil S.

Emory University
United States

Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms 5R01CA281932-02 Wendy Wang, Ph.D., M.Sc.
Labaer, Joshua

Arizona State University-Tempe Campus
United States

Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck 5R33CA281802-03 Wendy Wang, Ph.D., M.Sc.
Alexandrov, Ludmil B

University Of California, San Diego
United States

Mapping immuno-genomic drivers of the head and neck precancer invasive-disease transition 5U01CA290479-03 Wendy Wang, Ph.D., M.Sc.
Tanasova, Marina

Michigan Technological University
United States

Molecular probes for targeting facilitative fructose transporters (GLUTs) in biochemical and biomedical applications 2R15CA242401-02A1 Wendy Wang, Ph.D., M.Sc.